Skip to content
TrustList
Research Corporation Technologies logo
Venture capital firm

Research Corporation Technologies

Technology transfer and venture organisation commercialising life science inventions and biomedical tools

Research Corporation Technologies cover

About Research Corporation Technologies

From a life science idea to a patent and then a product, Research Corporation Technologies guides inventors and founders through each step. It describes its purpose as creating partnerships that change medicine, and it translates next-generation life science inventions from concept to patent and from patent to product. Its focus is biotechnology and medical devices, and it describes its role as offering biomedical innovators the experience, expertise and funding that success requires. It is connected to the Frederick Gardner Cottrell Foundation.

Licensing new biomedical technology to industry

The company licenses new and promising biomedical technologies and products to industry. Its list of technologies includes the CH2 domain scaffold known as ABDURINS, an endotoxin-free ClearColi expression system, a fibronectin artificial antibody scaffold, a granulocyte-macrophage colony stimulating factor, the Pichia classic expression platform, the GlyoSwitch protein expression system, ultrasound tissue harmonic imaging, and lacosamide, sold as VIMPAT, for the treatment of epileptic seizures.

Venture funding for early biomedical companies

Through its RCT Ventures program, the company provides venture capital to start-up and early-stage companies whose technologies could become significant biomedical products with a clear competitive edge. It also develops and invests in technologies that help discover and manufacture therapeutics and diagnostics, and many of these life science tools are available under nonexclusive licenses.

Protein expression and a medtech competition

Protein expression systems are a core part of what the company offers. In 2015 it announced, together with AdvaMed, that the finals of the MedTech Innovator competition would take place at AdvaMed's 2015 event. Its news feed also reports that AustinPx's KinetiSol technology received an advanced manufacturing technology designation from the US Food and Drug Administration's drug evaluation center.

TrustList summary

Research Corporation Technologies works with inventors and founders to turn life science ideas into patents and then into commercial products. Its focus is biotechnology and medical devices.

What Research Corporation Technologies does

  • Technology licensing: licenses new biomedical technologies and products to industry.
  • RCT Ventures: venture capital for start-up and early-stage companies with promising biomedical products.
  • Life science tools: technologies for discovering and making therapeutics and diagnostics, many available through nonexclusive licences.
  • Protein expression systems: including the Pichia platforms and the ClearColi system.

Who it works with

Entrepreneurs, inventors and biomedical companies. It also co-hosted the 2015 MedTech Innovator finals with AdvaMed.

Key facts

  • Related foundation: Frederick Gardner Cottrell Foundation
  • Sector: Biotechnology and medical devices

Summary written by TrustList from the business's own published information, Nov 2026.

Categories & features

  • Science
  • Series A
  • Early Stage
  • Series
  • Corporation

Ask TrustList to introduce you to Research Corporation Technologies

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA - Google Privacy Policy and Terms apply.

Reviews

Write the first review of Research Corporation Technologies

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about Research Corporation Technologies.

Research Corporation Technologies alternatives

Similar listings buyers compare against this one.

Early-stage investor turning scientific breakthroughs into industrial companies in energy, materials, mining and agriculture

Seed-stage investor in technology companies addressing social and environmental needs, from New York and Boston

Austin-based evergreen venture firm investing in software, technology-enabled and life science companies

Entrepreneur-led Australian venture capital firm providing Series A funding to high-growth technology startups

India and Japan startup accelerator helping Indian ventures prepare for funding and international expansion